Login / Signup

Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study.

Xiaomei LengWei LinShixue LiuKeith KanikCunshan WangWeiguo WanZhenyu JiangYi LiuShengyun LiuZhuoli ZhangZhiyi ZhangJian XuWenfeng TanJiankang HuJingyang LiJu LiuLevent M GunayOluwaseyi DinaCassandra D KinchXiaofeng Zeng
Published in: RMD open (2023)
NCT03486457.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • rheumatoid arthritis
  • phase iii
  • study protocol
  • ulcerative colitis
  • phase ii
  • randomized controlled trial